{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:47:58Z","timestamp":1782301678077,"version":"3.54.5"},"reference-count":42,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":3680,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:p>OBJECTIVES AND METHODS: A double\u2010blind, randomized, 6\u2010month clinical trial with parallel group design in 162 patients with gingivitis divided into three rinsing groups was conducted in order to study the efficacy and safety of a flavoured solution of delmopinol hydrochloride 2 mg ml\u201c\u2018 (0.2% w\/v, Decapinol Mouthwash\u201d<jats:sup>\u00ae<\/jats:sup>) used for supervised mouthrinsing in one rinsing group, in comparison with chlorhexidine digluconate 2 mg ml<jats:sup>\u20101<\/jats:sup> (0.2% w\/v, Hibitane Dental\u2019<jats:sup>a, b<\/jats:sup>) in a second rinsing group, and placebo in the third group. The criteria of the Plaque Index (PI) were used to assess plaque formation. Bleeding on probing (BOP) to the bottom of the pocket with a standard pressure was used as the primary gingivitis assessment. The occurrence of supragingival dental calculus and extrinsic tooth staining were also assessed. In addition, patients were asked to report adverse events at each visit.<\/jats:p><jats:p>RESULTS: Delmopinol and chlorhexidine exhibited lower scores of the mean PI and the BOP percentage than placebo, both at the 3\u2010month and 6\u2010month examinations. Furthermore, both active solutions showed a higher extent of staining of the teeth than placebo during these two observation periods. Rinsing with chlorhexidine resulted in more dental calculus than placebo after 6 months. Chlorhexidine showed lower scores for plaque formation and gingivitis development but higher scores of supragingival dental calculus (after 6 months) and tooth staining than did delmopinol. Both active solutions were reported by the patients\u2013approximately to the same extent but more frequently than placebo\u2013to induce taste alterations and a transient anaesthetic sensation of the oral mucosa. However, subjective staining of the teeth and tongue was reported by 16% of the delmopinol patients, but by 86% of the patients rinsing with chlorhexidine for 6 months. Furthermore, 24% of the patients in the chlorhexidine group, 9% in the delmopinol group and 4% in the placebo group wished to withdraw from treatment.<\/jats:p><jats:p>CONCLUSIONS: The results from this clinical trial indicate that supervised rinsing with 0.2% delmopinol hydrochloride or with 0.2% chlorhexidine digluconate twice daily for 60 s as a supplement to normal mechanical oral hygiene procedures resulted in less plaque formation and gingivitis than rinsing with placebo. Although chlorhexidine was more effective than delmopinol regarding plaque formation and gingivitis, it was considered by the patients as less tolerable.<\/jats:p>","DOI":"10.1111\/j.1601-0825.1998.tb00266.x","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T19:00:12Z","timestamp":1281034812000},"page":"105-113","source":"Crossref","is-referenced-by-count":47,"title":["Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months"],"prefix":"10.1111","volume":"4","author":[{"given":"NP","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JC","family":"Hase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHF","family":"H\u00e4mmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Kelty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Frutig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1716","article-title":"Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years","volume":"68","author":"Banting D","year":"1989","journal-title":"J Dent Res"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0889-5406(91)70069-9"},{"key":"e_1_2_1_4_1","first-page":"89","article-title":"The interdental bleeding index: a simplified procedure for monitoring gingival health","volume":"6","author":"Caton JB","year":"1985","journal-title":"Comp Contin Dent Education"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1996.tb02079.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1992.tb00466.x"},{"key":"e_1_2_1_7_1","first-page":"17","article-title":"Short\u2010term effect of topical application of delmopinol on salivary microbiology, plaque and gingivitis","volume":"102","author":"Collaert B","year":"1993","journal-title":"Scand J Dent Res"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1993.tb00367.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1993.tb00540.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1992.63.7.618"},{"key":"e_1_2_1_11_1","first-page":"0421","volume-title":"The rules governing medicinal products in the European community","author":"Committee for Proprietary Medicinal Products","year":"1990"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1968.39.3.142"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8177(86)24021-0"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1961.32.1.54"},{"key":"e_1_2_1_15_1","first-page":"119","article-title":"Side effects of chlorhexidine mouthwashes","volume":"69","author":"Flotra L","year":"1971","journal-title":"Scand J Dent Res"},{"key":"e_1_2_1_16_1","volume-title":"The scrip guide to Good Clinical Practice. Documenting clinical trials to US FDA requirements","author":"Gerlis L","year":"1990"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01008.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1989.60.8.435"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.1986.tb01513.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1995.tb00801.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0722.1995.tb00020.x"},{"key":"e_1_2_1_22_1","article-title":"Six month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I) Effect on plaque formation and gingivitis","volume":"25","author":"Hase JC","year":"1998","journal-title":"J Clin Periodontal."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1993.tb01754.x"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1993.tb01761.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1996.tb01822.x"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1981.tb02029.x"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.1982.tb01135.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1991.tb00424.x"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01553.x"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1967.38.6_part2.610"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.1976.tb00061.x"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016356309011240"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1992.tb02165.x"},{"key":"e_1_2_1_34_1","unstructured":"Nordic Council on Medicines(1989).Good clinical trial practice. Nordic guidelines. Uppsala Sweden .27\u20133."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1990.tb01108.x"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1992.tb00653.x"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.1986.tb01512.x"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.1986.tb01516.x"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016356408993968"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1991.tb00498.x"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1970.41.1.41"},{"key":"e_1_2_1_42_1","unstructured":"World Medical Association(1989).Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly Helsinki. Finland June 1964 and amended by the 29th World Medical Assembly Tokyo Japan October 1975 35th World Medical Assembly Venice Italy October 1983 and the 41 World Medical Assembly Hong Kong September 1989."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1993.tb00327.x"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.1998.tb00266.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.1998.tb00266.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:18:01Z","timestamp":1698452281000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.1998.tb00266.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1111\/j.1601-0825.1998.tb00266.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.1998.tb00266.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}